Aker BioMarine
| Company type | Public (OSE: AKBM) | 
|---|---|
| Industry | Marine biotechnology | 
| Headquarters | , | 
| Key people | Matts Johansen (CEO) Ola Snøve (chair) | 
| Revenue | 469 million kr (2012) | 
| NOK –35 million (2012) | |
| NOK –66 million (2012) | |
| Website | www | 
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM).